Nausea, constipation, and mild diarrhea are common but usually temporary and manageable with hydration and dietary adjustments
Tirzepatide, like many medications affecting metabolic processes, can cause a range of side effects
If diarrhea persists beyond the early dose escalation phase, even when you reach a stable dose, that warrants further investigation with a medical professional
Safety, tolerability, pharmacokinetics, and pharmacodynamics of concomitant administration of multiple doses of cagrilintide with semaglutide 2.4 mg for weight management: a randomised, controlled, phase 1b trial Summary: This Phase 1b trial assessed the safety, tolerability, pharmacokinetics, and pharmacodynamics of co-administering once-weekly subcutaneous cagrilintide (at various doses) with semaglutide 2.4 mg in participants for weight management
Intermittent fasting, on the other hand, requires adherence to specific time windows, which can be challenging in social situations or busy lifestyles
(2023e, July 26)